There is evidencenot only for the use of CXCR4 as a general marker for the progression andmetastasis of breast cancer, but also for the identification of individual tumorcells as they are homing from the primary tumor to secondary sites as patientsdevelop metastatic disease. Here, CXCR4 is linked to neoplasm.